Sun, Jun 25, 2017 | updated 03:54 PM IST

Post trial scientists develop tablet to prevent kidney cancer relapse

Updated: Oct 12, 2016 12:22 IST      
Post trial scientists develop tablet to prevent kidney cancer relapse

Washington D.C [USA], Oct. 12 (ANI): A recent trial demonstrates that consuming oral tablet Sunitinib for one year reduces the likelihood of cancer returning for kidney cancer patients following removal of the

kidney.

Reportedly, it is the first ever preventative treatment to make a difference to kidney cancer patients after surgery.

Patients with locally advanced kidney cancer usually face a 40 to 50 percent chance of a relapse within five years after having an operation to remove their kidney.

The clinical trial of an adjuvant treatment for patients, who have had kidney cancer, has been carried out by an international team of oncology experts.

The results of the trial are likely to change clinical practice worldwide.

Kidney cancer accounts for 129,000 deaths worldwide each year and patients with locally advanced kidney cancer face a 50 percent risk of it returning within five years once they have had the operation to

remove their kidney.

While adjuvant treatments are routinely used on patients with other types of cancer (such as breast and bowel cancer), no such treatment capable of improving outcomes for kidney cancer patients have been developed yet.

This is despite numerous studies being carried out in this field over the past 20 years.

The recent research demonstrates that by taking the oral tablet Sunitinib for one year, patients are able to reduce the likelihood of their cancer returning.

The trial, a randomised double blind test was conducted with 615 people with stage T3 renal cell carcinoma, some of whom were given Sunitinib and some a placebo.

Patients receiving Sunitinib had improved disease free survival versus those given the placebo (6.8 years versus 5.6 years).

Sunitinib is a tried and tested drug which has been used on patients with metastatic (widespread) renal cancer for around eight years.

In the trial, as expected, the incidence of side-effects in patients taking Sunitinib was higher to those taking the placebo but these side effects were manageable and did not lay impact on the patients' quality of life.

The trial was led in the UK by Hardev Pandha and its lead researcher was Alain Ravaud.

"This trial was undertaken with a very well-defined population of patients who are generally at high risk of relapse. For these patients, it has shown that taking a simple tablet makes a significant difference without causing a significant decrease in quality of life. Since Sunitinib is already widely used in patients with metastatic

cancer, clinicians are familiar with the drug and its side-effects, so are well placed to prescribe it to patients," Pandha said.

The results of the trial were presented during the Presidential Address of the ESMO 2016 Congress in Copenhagen. (ANI)

Paracetamol during pregnancy can put unborn boys at risk

Updated: Jun 25, 2017 14:45 IST     

New Delhi [India] June 24, (ANI): Pregnant? You may want to rethink popping those paracetamol pills as a recent study has suggested that doing so can harm the masculinity of your unborn son.

Full Story >>

Excessive texting is bad for your wrists

Updated: Jun 25, 2017 11:48 IST     

New York [US], June 25 (ANI): Texting, the thing we do most with our phones, takes a toll on our health.

Full Story >>

Ozone exposure ups autism odds in at-risk people

Updated: Jun 24, 2017 19:47 IST     

Washington D.C. [USA], Jun 24 (ANI): Elevated exposure to ozone can put individuals with high levels of genetic variation at an even higher risk for developing autism than would be expected by adding the two risk factors together, according to a recent analysis.

Full Story >>

Washington D.C. [USA], June 24 (ANI): People suffering from advanced kidney cancer, we have some good news for you.

Full Story >>

Washington D.C. [USA], June 24 (ANI): In a recent study, leisure activities like going for a walk outside, reading, listening to music and other fun activities can reduce blood pressure for elderly caregivers of spouses with Alzheimer's disease.

Full Story >>

Anti-epilepsy drug to treat Alzheimer's disease?

Updated: Jun 24, 2017 10:09 IST     

Washington D.C. [USA], June 24 (ANI): According to a recent study, the scientists have tested an anti-epileptic drug for its potential impact on the brain activity of patients with mild Alzheimer's disease.

Full Story >>

Take these measures to keep oral cancer at bay

Updated: Jun 23, 2017 16:04 IST     

New Delhi [India], June 23 (ANI): Oral Cancer is one of the most prevalent forms of cancer in India. Evidence suggests that India bears the largest burden of oral cancers in the world, with an incidence of around 11.28 percent in Indian men.

Full Story >>

Don't eat but sleep, to beat office blues!

Updated: Jun 23, 2017 10:59 IST     

Washington D.C. [USA], June 23 (ANI): Stressful day at work leads to binge-eating at night. A new study suggests a good night's sleep can serve as a protecting factor between job stress and unhealthy eating in the evening.

Full Story >>

Washington D.C. [USA], June 23 (ANI): According to a recent clinical trial, intensive blood pressure lowering benefits patients with chronic kidney disease.

Full Story >>

New Delhi, [India], June 22 (ANI): J K Organization, in collaboration with Pushpawati Singhania Hospital and Research Institute Multispecialty Hospital, organized a two-day blood donation camp in New Delhi to collect 4043 units of blood.

Full Story >>

Can your blood group predict heart attack risk?

Updated: Jun 22, 2017 13:12 IST     

New Delhi [India], June 22 (ANI): India is presently witnessing nearly two million heart attacks annually. A heart attack (clinically known as myocardial infarction) is the permanent damage or death of the heart muscles due to lack of oxygen-rich blood. According to reports, heart attack kills one person in every 33 seconds in our country.

Full Story >>

Deficits in attention linked to increased alcohol use

Updated: Jun 22, 2017 13:02 IST     

Washington D.C. [USA], June 22 (ANI): Finding it hard to multi-task? Your frequency of alcohol use could be a reason.

Full Story >>

Healing garden at your place: Homoeopathy speaks

Updated: Jun 22, 2017 13:01 IST     

New Delhi [India], June 22 (ANI): One always aspires to be fit and healthy without taking any medicine. If there will be no stress, infections or any other disturbances, there will be no chance of getting ill. But the real world is exactly opposite. There is no life without challenges.

Full Story >>

Looking for stone removal procedure?

Updated: Jun 22, 2017 11:48 IST     

New Delhi [India], June 22 (ANI): Kidneys help in detoxifying and filtering impurities from the blood. They help us excrete excess toxins and excess water through urine.

Full Story >>

Lack Vitamin D? Your job could be a reason

Updated: Jun 22, 2017 09:35 IST     

Washington D.C. [USA], June 22 (ANI): Stuck behind your office desk for most part of the day? Your nine-to-five job could be a major factor that puts you at high risk of Vitamin D deficiency.

Full Story >>

New Delhi [India], Jun 21 (ANI): In a major breakthrough in kidney transplant, a team of doctors has conducted an ABO incompatible kidney transplant on the youngest child in SAARC region.

Full Story >>

Washington D.C. [USA], June 21 (ANI): The proverb early to bed and early to rise makes man healthy, wealthy and wise, rightly explains a recent study, as it suggests people who sleep after 3 a.m. at night have lower perceived control of obsessive thoughts.

Full Story >>

Exhaustion of immune cells linked to irritable bowel syndrome

Updated: Jun 21, 2017 12:50 IST     

Washington D.C. [USA], June 21 (ANI): Australian researchers have recently discovered that exhaustion of the immune system is linked to a specific type of an intestinal disorder causing pain in the stomach, wind, diarrhea and constipation.

Full Story >>

Nerves from foot used to restore vision of 60-year-old

Updated: Jun 19, 2017 19:58 IST     

New Delhi [India], June 19 (ANI): In a first of its kind surgery, a hospital in Mumbai used nerves from the foot of a partially blind 60-year-old woman to help her restore her vision.

Full Story >>

Now, it's easier to blunt sickle cell disease

Updated: Jun 19, 2017 16:28 IST     

New Delhi [India], June 19 (ANI): As population of sickle cell poses a formidable challenge, odds have dramatically lessened in its treatment.

Full Story >>